Citi initiates Madrigal Pharmaceuticals coverage with Buy rating

September 23, 2026 5:03 AM

(Updated - September 23, 2026 5:04 AM EDT)

Citi analyst Eric Joseph initiated coverage on Madrigal Pharmaceuticals (NASDAQ: MDGL) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found